(JKS) JinkoSolar Holding - Ratings and Ratios
Solar Modules, Silicon Wafers, Solar Cells, Recovered Silicon, Silicon Ingots
Dividends
| Dividend Yield | 5.24% |
| Yield on Cost 5y | 2.68% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 98.3% |
| Payout Ratio | 388.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 65.4% |
| Value at Risk 5%th | 98.6% |
| Relative Tail Risk | -8.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.23 |
| Alpha | -8.56 |
| CAGR/Max DD | -0.20 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.610 |
| Beta | 1.060 |
| Beta Downside | 1.936 |
| Drawdowns 3y | |
|---|---|
| Max DD | 73.81% |
| Mean DD | 46.92% |
| Median DD | 52.12% |
Description: JKS JinkoSolar Holding November 17, 2025
JinkoSolar Holding Co., Ltd. (NYSE:JKS) designs, manufactures, and markets a full suite of photovoltaic products-including mono-silicon wafers, solar cells, modules, and recovered silicon-while also offering system integration, EPC, and energy-storage services for solar power projects worldwide.
As of 31 December 2024 the firm reported an integrated annual capacity of 120 GW of mono wafers, 95 GW of cells, and 130 GW of modules, positioning it among the top three global module manufacturers by volume.
Key operational metrics from the latest quarter (Q3 2024) show a 12 % YoY increase in module shipments to 13.2 GW, a gross margin of 21.5 % (up from 19.8 % in Q3 2023), and a cash conversion cycle of 45 days, reflecting improved supply-chain efficiency and higher realized ASPs driven by the resurgence of U.S. tax-credit incentives.
Sector drivers that materially affect JinkoSolar’s outlook include the International Energy Agency’s forecast of a 30 % rise in global solar capacity additions through 2028, the tightening of polysilicon supply due to stricter environmental regulations in China, and the accelerating rollout of utility-scale storage projects that create bundled revenue streams for module OEMs.
For a data-rich, scenario-based assessment of JinkoSolar’s valuation relative to peers, the ValueRay platform offers granular financial models and sensitivity analyses worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-2.52b TTM) > 0 and > 6% of Revenue (6% = 4.51b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 7.76pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.32% (prev 5.04%; Δ 16.29pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 16.85b > Net Income -2.52b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (13.1m) change vs 12m ago -0.21% (target <= -2.0% for YES) |
| Gross Margin 7.28% (prev 14.00%; Δ -6.72pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 60.25% (prev 79.27%; Δ -19.02pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.12 (EBITDA TTM -2.89b / Interest Expense TTM 1.31b) >= 6 (WARN >= 3) |
Altman Z'' 1.29
| (A) 0.13 = (Total Current Assets 69.96b - Total Current Liabilities 53.93b) / Total Assets 120.84b |
| (B) 0.07 = Retained Earnings (Balance) 8.64b / Total Assets 120.84b |
| (C) -0.00 = EBIT TTM -152.5m / Avg Total Assets 124.74b |
| (D) 0.19 = Book Value of Equity 17.10b / Total Liabilities 90.73b |
| Total Rating: 1.29 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 47.04
| 1. Piotroski 3.0pt |
| 2. FCF Yield 21.05% |
| 3. FCF Margin 9.95% |
| 4. Debt/Equity 2.89 |
| 5. Debt/Ebitda -8.97 |
| 6. ROIC - WACC (= -2.29)% |
| 7. RoE -13.36% |
| 8. Rev. Trend 28.28% |
| 9. EPS Trend -47.62% |
What is the price of JKS shares?
Over the past week, the price has changed by -5.13%, over one month by +0.12%, over three months by +2.27% and over the past year by +5.34%.
Is JKS a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 3
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the JKS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37.4 | 50.9% |
| Analysts Target Price | 37.4 | 50.9% |
| ValueRay Target Price | 23.9 | -3.7% |
JKS Fundamental Data Overview November 27, 2025
P/E Forward = 53.7634
P/S = 0.0193
P/B = 0.5538
P/EG = 0.2568
Beta = 0.456
Revenue TTM = 75.16b CNY
EBIT TTM = -152.5m CNY
EBITDA TTM = -2.89b CNY
Long Term Debt = 30.52b CNY (from longTermDebt, last quarter)
Short Term Debt = 18.61b CNY (from shortTermDebt, last quarter)
Debt = 49.37b CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = 25.93b CNY (from netDebt column, last quarter)
Enterprise Value = 35.54b CNY (9.61b + Debt 49.37b - CCE 23.44b)
Interest Coverage Ratio = -0.12 (Ebit TTM -152.5m / Interest Expense TTM 1.31b)
FCF Yield = 21.05% (FCF TTM 7.48b / Enterprise Value 35.54b)
FCF Margin = 9.95% (FCF TTM 7.48b / Revenue TTM 75.16b)
Net Margin = -3.36% (Net Income TTM -2.52b / Revenue TTM 75.16b)
Gross Margin = 7.28% ((Revenue TTM 75.16b - Cost of Revenue TTM 69.69b) / Revenue TTM)
Gross Margin QoQ = 7.31% (prev -2.55%)
Tobins Q-Ratio = 0.29 (Enterprise Value 35.54b / Total Assets 120.84b)
Interest Expense / Debt = 0.66% (Interest Expense 326.8m / Debt 49.37b)
Taxrate = 14.69% (-191.6m / -1.30b)
NOPAT = -130.1m (EBIT -152.5m * (1 - 14.69%)) [loss with tax shield]
Current Ratio = 1.30 (Total Current Assets 69.96b / Total Current Liabilities 53.93b)
Debt / Equity = 2.89 (Debt 49.37b / totalStockholderEquity, last quarter 17.10b)
Debt / EBITDA = -8.97 (negative EBITDA) (Net Debt 25.93b / EBITDA -2.89b)
Debt / FCF = 3.47 (Net Debt 25.93b / FCF TTM 7.48b)
Total Stockholder Equity = 18.88b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.09% (Net Income -2.52b / Total Assets 120.84b)
RoE = -13.36% (Net Income TTM -2.52b / Total Stockholder Equity 18.88b)
RoCE = -0.31% (EBIT -152.5m / Capital Employed (Equity 18.88b + L.T.Debt 30.52b))
RoIC = -0.20% (negative operating profit) (NOPAT -130.1m / Invested Capital 66.26b)
WACC = 2.09% (E(9.61b)/V(58.98b) * Re(9.92%) + D(49.37b)/V(58.98b) * Rd(0.66%) * (1-Tc(0.15)))
Discount Rate = 9.92% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -51.62%
[DCF Debug] Terminal Value 62.48% ; FCFE base≈7.48b ; Y1≈4.91b ; Y5≈2.25b
Fair Price DCF = 645.6 (DCF Value 33.35b / Shares Outstanding 51.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -47.62 | EPS CAGR: -2.08% | SUE: 3.30 | # QB: 2
Revenue Correlation: 28.28 | Revenue CAGR: 18.43% | SUE: 0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.22 | Chg30d=+0.690 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.23 | Chg30d=+2.476 | Revisions Net=+0 | Growth EPS=+131.2% | Growth Revenue=+41.4%
Additional Sources for JKS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle